The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy

B Hou, T Chen, H Zhang, J Li, P Wang… - Frontiers in …, 2023 - frontiersin.org
The tumor microenvironment (TME) is the tumor surrounding environment, which is critical
for tumor development and progression. TME is also involved in clinical intervention and …

Radiation-targeted immunotherapy: A new perspective in cancer radiotherapy

L Xuan, C Bai, Z Ju, J Luo, H Guan, PK Zhou… - Cytokine & Growth …, 2024 - Elsevier
In contemporary oncology, radiation therapy and immunotherapy stand as critical
treatments, each with distinct mechanisms and outcomes. Radiation therapy, a key player in …

Altered glycosylation in cancer: molecular functions and therapeutic potential

X Xu, Q Peng, X Jiang, S Tan, W Yang… - Cancer …, 2024 - Wiley Online Library
Glycosylation, a key mode of protein modification in living organisms, is critical in regulating
various biological functions by influencing protein folding, transportation, and localization …

Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation

H Tong, Z Jiang, L Song, K Tan, X Yin, C He, J Huang… - Cell Metabolism, 2024 - cell.com
The effect of the serine/glycine-free diet (− SG diet) on colorectal cancer (CRC) remains
unclear; meanwhile, programmed death-1 (PD-1) inhibitors are less effective for most CRC …

Assembly of DNA triangular pyramid frustum for ultrasensitive quantification of exosomal miRNA

R Xia, H Chai, J Jiao, P Miao - Biosensors and Bioelectronics, 2023 - Elsevier
Early screening of biomarkers benefits therapy and prognosis of cancers. MiRNAs
encapsulated in tumor-derived exosomes are emerging biomarkers for early diagnosis of …

[HTML][HTML] Chemo-immunotherapy by dual-enzyme responsive peptide self-assembling abolish melanoma

Y Wang, L Xie, X Li, L Wang, Z Yang - Bioactive Materials, 2024 - Elsevier
Herein, we designed Comp. 1 to simultaneously respond to two enzymes: alkaline
phosphatase and matrix metalloproteinase 2, which is commonly found in highly malignant …

N-linked glycosylation of PD-L1/PD-1: An emerging target for cancer diagnosis and treatment

Z Duan, R Shi, B Gao, J Cai - Journal of Translational Medicine, 2024 - Springer
During tumorigenesis and progression, the immune checkpoint programmed death-1 (PD-1)
and its ligand programmed death ligand-1 (PD-L1) play critical roles in suppressing T cell …

Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets

Z Hong, F Liu, Z Zhang - Experimental Hematology & Oncology, 2024 - Springer
Although immune checkpoint-based cancer immunotherapy has shown significant efficacy
in various cancers, resistance still limits its therapeutic effects. Ubiquitination modification is …

New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer

Z Li, X Yu, Z Yuan, L Li, P Yin - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Abstract Programmed death-ligand 1 (PD-L1) has become a crucial focus in cancer
immunotherapy considering it is found in many different cells. Cancer cells enhance the …

Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation

X Xu, T Xie, M Zhou, Y Sun, F Wang, Y Tian… - Nature …, 2024 - nature.com
Immune checkpoint inhibition targeting the PD-1/PD-L1 pathway has become a powerful
clinical strategy for treating cancer, but its efficacy is complicated by various resistance …